Internal documents suggest that the vaccine manufacturer negotiated for months on the sale of its mRNA laboratories in Tübingen – and then broke off. Interested parties appear to be appalled.
Internal documents suggest that the vaccine manufacturer negotiated for months on the sale of its mRNA laboratories in Tübingen – and then broke off. Interested parties appear to be appalled.